Vetsys Pharmaceutical
Vetsys Pharmaceutical
High-efficacy intramammary infusions engineered for local livestock health.
Jakarta, as the economic heartbeat of Indonesia, serves as a critical hub for the distribution and manufacture of advanced veterinary medicines, particularly Intramammary Infusions. With the rising demand for dairy products in the Greater Jakarta area (Jabodetabek) and the surrounding dairy clusters in West Java (Lembang and Pangalengan), the need for effective mastitis control is at an all-time high. Our presence as a premier supplier bridges the gap between high-tech pharmaceutical manufacturing and the localized needs of Indonesian farmers.
The industrial landscape in Jakarta is rapidly evolving. As a gateway for international trade via the Tanjung Priok port, Jakarta allows for the seamless integration of global pharmaceutical standards into the local Indonesian market. Our factory and supply chains are optimized to meet the stringent requirements of the Ministry of Agriculture of the Republic of Indonesia (Kementan) and BPOM, ensuring that every batch of Cefquinome Sulfate or Amoxicillin infusion meets international GMP standards while being adapted to the tropical environmental challenges of the region.
Located near Jakarta's major transit points, we ensure rapid delivery of temperature-sensitive intramammary syringes to dairy cooperatives across Indonesia.
Our production lines operate under strict Good Manufacturing Practices, ensuring zero contamination in our mastitis treatment solutions.
With a capital of 30 million RMB and global reach, we are a dominant force in the veterinary drug industry, supporting Jakarta's animal health infrastructure.
The industry is shifting towards "Smart Veterinary Medicine." In Jakarta and surrounding industrial zones, there is a growing trend toward using fourth-generation cephalosporins like Cefquinome Sulfate. Unlike older treatments, these advanced infusions offer higher bioavailability and shorter withdrawal periods, which is vital for the Jakarta dairy market where milk quality and safety are strictly monitored by local health authorities.
Our research institute is currently pioneering AI-driven formulation testing. By analyzing the bacterial strains common in Indonesian dairy cattle, such as Staphylococcus aureus and Streptococcus agalactiae, we customize our Intramammary Infusions to be more effective against local resistance patterns. This level of Technical Innovation sets us apart from standard wholesalers in the region.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015. Our expansion into the Jakarta and Indonesian market marks a new chapter in our global strategy.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands—such as the unique veterinary requirements in Jakarta—and produce cutting-edge solutions for animal health.
Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in animal healthcare.
Quality is the cornerstone of our operations. Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market. Vetsys believes that excellence in product quality is essential to long-term growth and sustainability, maintaining trust and loyalty among our Jakarta-based partners.
State-of-the-art production lines for high-purity intramammary delivery systems.
In the context of Jakarta's commercial livestock sector, intramammary infusions are used in three primary scenarios:
Our Vision at Vetsys is to improve animal health through continuous innovation and sustainable practices. As we expand our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide, we remain committed to creating value for our Jakarta partners, employees, and the broader agricultural society.
Advanced antibiotic and anti-inflammatory formulations for modern Jakarta farming.
